Alpha 2.0
Login Register
» Articles » PMID: 20018366

Large Trials Confirm Immunogenicity of H1N1 Vaccines

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2009 Dec 19
PMID 20018366
Citations 7
Authors
Heath Kelly
Ian Barr
Affiliations
Soon will be listed here.
Citing Articles

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.

Sullivan S, Price O, Regan A Ther Adv Vaccines Immunother. 2019; 7:2515135519826481.

PMID: 30793097 PMC: 6376509. DOI: 10.1177/2515135519826481.

A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Herbinger K, von Sonnenburg F, Nothdurft H, Perona P, Borkowski A, Fragapane E Hum Vaccin Immunother. 2013; 10(1):92-9.

PMID: 24047817 PMC: 4181038. DOI: 10.4161/hv.26495.

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

Kelly H, Sullivan S, Grant K, Fielding J Influenza Other Respir Viruses. 2012; 7(5):729-37.

PMID: 23078073 PMC: 5781205. DOI: 10.1111/irv.12018.

Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.

Manzoli L, De Vito C, Salanti G, DAddario M, Villari P, Ioannidis J PLoS One. 2011; 6(9):e24384.

PMID: 21915319 PMC: 3167852. DOI: 10.1371/journal.pone.0024384.

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Bodewes R, Kreijtz J, Geelhoed-Mieras M, van Amerongen G, Verburgh R, van Trierum S J Virol. 2011; 85(6):2695-702.

PMID: 21228239 PMC: 3067975. DOI: 10.1128/JVI.02371-10.